V
Verve Therapeutics
Cambridge, United States
Founded 2018 NASDAQ: VERV
About
Gene editing company for cardiovascular disease using base editing and LNP delivery
Company Details
- Type
- public
- Employees
- 200+
- Funding
- Public
Key Products
- VERVE-101
- VERVE-102